New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome
Diagnostics · 07.02.2023 · 13 (4) · 613
DOI: 10.3390/diagnostics13040613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 07.02.2023. Verfasst von Beatrice Dal Zotto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente funding.
Abstract (Originalsprache)
The indications for the treatment of patients with known atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are clear, while less is available about the management of new-onset AF (NOAF) during ST-segment elevation myocardial infarction (STEMI). The aim of this study is to evaluate mortality and clinical outcome of this high-risk subgroup of patients. We analyzed 1455 consecutive patients undergoing PCI for STEMI. NOAF was detected in 102 subjects, 62.7% males, with a mean age of 74.8 ± 10.6 years. The mean ejection fraction (EF) was 43.5 ± 12.1% and the mean atrial volume was increased (58 ± 20.9 mL). NOAF occurred mainly in the peri-acute phase and had a very variable duration (8.1 ± 12.5 min). During hospitalization, all the patients were treated with enoxaparin, but only 21.6% of them were discharged with long term oral anticoagulation. The majority of patients had a CHA2DS2-VASc score >2 and a HAS-BLED score of 2 or 3. The in-hospital mortality was 14.2%, while the 1-year mortality was 17.2% and long-term mortality 32.1% (median follow-up 1820 days). We identified age as an independent predictor of mortality both at short- and long-term follow-ups, while EF was the only independent predictor for in-hospital mortality and arrhythmia duration for 1-year mortality. At the 1-year follow-up, we recorded three ischemic strokes and no bleeding complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- UOC Cardiology, ASST Santi Paolo e Carlo, 20142 Milan, Italy.
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
ORCID-Profile: Lucia Barbieri, Gabriele Tumminello, Stefano Carugo
Förderung
- Ricerca Corrente funding
Zitieren
APA
Dal Zotto, B., Barbieri, L., Tumminello, G., Saviano, M., Gentile, D., Lucreziotti, S., Frattini, L., Tarricone, D., & Carugo, S. (2023). New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome. Diagnostics, 13(4), 613. https://doi.org/10.3390/diagnostics13040613
Vancouver
Dal Zotto B, Barbieri L, Tumminello G, Saviano M, Gentile D, Lucreziotti S, et al. New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome. Diagnostics. 2023;13(4):613. doi:10.3390/diagnostics13040613
BibTeX
@article{DalZotto2023,
author = {Dal Zotto, Beatrice and Barbieri, Lucia and Tumminello, Gabriele and Saviano, Massimo and Gentile, Domitilla and Lucreziotti, Stefano and Frattini, Loredana and Tarricone, Diego and Carugo, Stefano},
title = {New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {4},
pages = {613},
doi = {10.3390/diagnostics13040613}
}
EUVIMED